Evidence map›Paper›PMID 35747077›Full record

ArticleRSC advances2021

Applying molecular networking for targeted isolation of depsipeptides.

Xiao Lin, Ling Chai, Hong Rui Zhu, Yongjun Zhou, Yaoyao Shen, Kai Hao Chen, Fan Sun, Bu Ming Liu, Shi Hai Xu, Hou Wen Lin

Abstract read
In one paragraph

Article in RSC advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. New Hydrogenated Phenanthrene Glycosides from the Edible VegetableJournal of agricultural and food chemistry · 2025
    Article
  2. Article
  3. UPLC-Q-TOF-MS/MS Analysis ofFrontiers in microbiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Xiao LinInstitute of Marine Drugs, Guangxi University of Chinese Medicine Nanning 530200 P. R. China.ORCID https://orcid.org/0000-0001-7278-2062
Ling ChaiGuangxi Key Laboratory of Traditional Chinese Medicine Quality Standards, Guangxi Institute of Traditional Medical and Pharmaceutical Sciences Nanning 530022 P. R. China.
Hong Rui ZhuResearch Center for Marine Drugs, State Key Laboratory of Oncogenes and Related Genes, Department of Pharmacy, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University Shanghai 200127 P. R. China franklin67@126.com.
Yongjun ZhouResearch Center for Marine Drugs, State Key Laboratory of Oncogenes and Related Genes, Department of Pharmacy, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University Shanghai 200127 P. R. China franklin67@126.com.
Yaoyao ShenResearch Center for Marine Drugs, State Key Laboratory of Oncogenes and Related Genes, Department of Pharmacy, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University Shanghai 200127 P. R. China franklin67@126.com.
Kai Hao ChenResearch Center for Marine Drugs, State Key Laboratory of Oncogenes and Related Genes, Department of Pharmacy, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University Shanghai 200127 P. R. China franklin67@126.com.
Fan SunResearch Center for Marine Drugs, State Key Laboratory of Oncogenes and Related Genes, Department of Pharmacy, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University Shanghai 200127 P. R. China franklin67@126.com.
Bu Ming LiuGuangxi Key Laboratory of Traditional Chinese Medicine Quality Standards, Guangxi Institute of Traditional Medical and Pharmaceutical Sciences Nanning 530022 P. R. China.
Shi Hai XuCollege of Chemistry and Materials, Jinan University Guangzhou 510632 P. R. China txush@jnu.edu.cn.
Hou Wen LinResearch Center for Marine Drugs, State Key Laboratory of Oncogenes and Related Genes, Department of Pharmacy, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University Shanghai 200127 P. R. China franklin67@126.com.ORCID https://orcid.org/0000-0002-7097-0876

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

LC-HRMS/MS molecular networking enabled the targeted isolation of three new neoantimycin analogs (1, 3, 5) and two known ones (2, 4) from the culture broth of

Identifiers

PMID35747077
PMCPMC9134009

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.